Screener
Revolution Medicines, Inc. RVMD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -79.1%-32.5pp | -76.7%-40.0pp | -58.1%-28.7pp | -60.8%-13.6pp | -46.6%-5.9pp | |
| Return on invested capital | -91.9%-32.6pp | -89.6%-43.2pp | -72.4%-27.6pp | -69.4%-3.8pp | -59.3%-0.5pp | |
| Liquidity | ||||||
| Current ratio | 11.4×-0.4× | 6.8×-6.7× | 7.1×-7.1× | 8.1×-6.2× | 11.8×-3.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $12.36+24.9% | $7.57-31.5% | $8.58-36.5% | $8.44-10.1% | $9.89+0.9% | |
| Valuation | ||||||
| Market capitalization | $40.32B+353% | $19.27B+193% | $15.4B+90.5% | $8.73B+15.4% | $7.46B+16.3% | |
| Price / book | 15.5×+9.9× | 12.8×+9.7× | 9.4×+5.9× | 5.5×+0.6× | 4×0.0× |
FAQ
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.